Is hispanic race an independent risk factor for pathological stage in patients undergoing radical prostatectomy?

Journal of Urology

Volumn 170, Issue 6 I, 2003, Pages 2288-2291

  Lam, John S ^a   Desai, Manisha ^b   Mansukhani, Mahesh M ^a   Benson, Mitchell C ^a   Goluboff, Erik T ^a  

^a Columbia Univ Coll of Phys/Surgs ^*  (United States)

^b NEW YORK PRESBYTERIAN HOSPITAL   (United States)

Author keywords

Hispanic Americans; Prostate; Prostate specific antigen; Prostatectomy; Prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE; AGED; ARTICLE; CANCER GRADING; CANCER INVASION; CANCER LOCALIZATION; CANCER STAGING; CAUCASIAN; ETHNIC GROUP; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; RISK FACTOR;

EID: 0242440215     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000091101.31497.71     Document Type: Article

References (20)

1. del Pinal, J. H.: Hispanic Americans in the United States: young, dynamic, and diverse. Stat Bull Metrop Insur Co, 77: 2, 1996
2. Jemal, A., Thomas, A., Murray, T. and Thun, M.: Cancer statistics, 2002. CA Cancer J Clin, 52: 23, 2002
3. Canto, M. T. and Chu, K. C.: Annual cancer incidence rates for Hispanics in the United States. Cancer, 88: 2642, 2000
4. Morton, R. A., Jr.: Racial differences in adenocarcinoma of the prostate in North American men. Urology, 44: 637, 1994
5. Optenberg, S. A., Thompson, I. M., Friedrichs, P., Wojcik, B., Stein, C. R. and Kramer, B.: Race, treatment, and long-term survival from prostate cancer in an equal-access medical care delivery system. JAMA, 274: 1599, 1995
6. Hoffman, R. M., Gilliland, F. D., Eley, J. W., Harlan, L. C., Stephenson, R. A., Stanford, J. L. et al: Racial and ethnic differences in advanced-stage prostate cancer: The Prostate Cancer Outcomes Study. J Natl Cancer Inst, 93: 388, 2001
7. Danley, K. L., Richardson, J. L., Bernstein, L., Langholz, B. and Ross, R. K.: Prostate cancer: trends in mortality and stage-specific incidence rates by racial/ethnic group in Los Angeles County, California (United States). Cancer Causes Control, 6: 492, 1995
8. Delfino, R. J., Ferrini, R. L., Taylor, T. H., Howe, S. and Anton-Culver, H.: Demographic differences in prostate cancer incidence and stage: an examination of population diversity in California. Am J Prev Med, 14: 96, 1998
9. Moul, J. W., Douglas, T. H., McCarthy, W. F. and McLeod, D. G.: Black race is an adverse prognostic factor for prostate cancer recurrence following radical prostatectomy in an equal access health care setting. J Urol, 155: 1667, 1996
10. Powell, I. J., Heilburn, L. K., Sakr, W., Grignon, D., Montie, J., Novallo, M. et al: The predictive value of race as a clinical prognostic factor among patients with clinically localized prostate cancer: a multivariate analysis of positive surgical margins. Urology, 49: 726, 1997
11. Pettaway, C. A., Troncoso, P., Ramirez, E. I., Johnston, D. A., Steelhammer, L. and Babaian, R. J.: Prostate specific antigen and pathological features of prostate cancer in black and white patients: a comparative study based on radical prostatectomy specimens. J Urol, 160: 437, 1998
12. Barroso, U., Jr., Oskanian, P., Tefilli, M. V., Banerjee, M., Grignon, D., Sakr, W. et al: Population-based study of pelvic lymph node positivity in clinically localized prostate cancer: a study comparing African Americans and whites. Urology, 53: 187, 1999
13. Bianco, F. J., Jr., Wood, D. P., Jr., Grignon, D. J., Sakr, W. A., Pontes, J. E. and Powell, I. J.: Prostate cancer stage shift has eliminated the gap in disease-free survival in black and white American men after radical prostatectomy. J Urol, 168: 479, 2002
14. Paquette, E. L., Connelly, R. R., Sesterhenn, I. A., Zhang, W., Sun, L., Paquette, L. R. et al: Improvements in pathologic staging for African-American men undergoing radical retropubic prostatectomy during the prostate specific antigen era: implications for screening a high-risk group for prostate carcinoma. Cancer, 92: 2673, 2001
15. Freedland, S. J., Dorey, F. and Aronson, W. J.: Multivariate analysis of race and adverse pathologic findings after radical prostatectomy. Urology, 56: 807, 2000
16. Vollmer, R. T. and Montana, G. S.: Predicting tumor failure in prostate carcinoma after definitive radiation therapy: limitations of models based on prostate-specific antigen, clinical stage, and Gleason score. Clin Cancer Res, 5: 2476, 1999
17. Therrien, M. and Ramirez, R. R.: The Hispanic Population in the United States: March 2000, Current Population Reports, P20-535. Washington, D. C.: United States Census Bureau, March 2001
18. Makridakis, N. M., Ross, R. K., Pike, M. C., Crocitto, L. E., Kolonel, L. N., Pearce, C. L. et al: Association of mis-sense substitution in SRD5A2 gene with prostate cancer in African-American and Hispanic men in Los Angeles, USA. Lancet, 354: 975, 1999
19. Stamey, T. A., Yang, N., Hay, A. R., McNeal, J. E., Freiha, F. S. and Redwine, E.: Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med, 317: 909, 1987
20. Stewart, S. L., Swallen, K. C., Glaser, S. L., Horn-Ross, P. L. and West, D. W.: Comparison of methods for classifying Hispanic ethnicity in a population-based cancer registry. Am J Epidemiol, 149: 1063, 1999